Sökning: onr:"swepub:oai:DiVA.org:umu-143707" >
Ferritinemia and se...
Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1
-
- Lorenz, Fryderyk (författare)
- Umeå universitet,Onkologi
-
Pawlowicz, Ewa (författare)
-
Klimkowska, Monika (författare)
-
visa fler...
-
- Beshara, Soheir (författare)
- Karolinska Institutet
-
Brustad, Agnes Bulanda (författare)
-
Skotnicki, Aleksander B. (författare)
-
- Wahlin, Anders (författare)
- Umeå universitet,Onkologi
-
- Machaczka, Maciej (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- ACADEMIC PRESS INC ELSEVIER SCIENCE, 2018
- 2018
- Engelska.
-
Ingår i: Blood Cells, Molecules & Diseases. - : ACADEMIC PRESS INC ELSEVIER SCIENCE. - 1079-9796 .- 1096-0961. ; 68, s. 35-42
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: The storage of glucosylceramide in macrophages produces an inflammatory response in Gaucher disease type 1 (GD1) resulting in iron metabolism dysregulation and cytokine release. Patients and methods: The study included 16 adults with GD1 aged 20-86 years. All but one patient carried at least one allele with the c.1226A > G (N370S) mutation in the GBA1 gene. Ferritinemia, iron metabolism profiles including hepcidin, and inflammatory cytokine concentrations were assessed in GD1 patients in Sweden. Results: Hyperferritinemia was present in 81% of patients. There was no correlation between hyperferritinemia and patient's gender, spleen status, or clinical status. Hepcidin was discrepantly low in relation to ferritin levels. TNF-alpha was moderately increased in 5 of 11 patients; 2 patients with the highest TNF-alpha concentrations showed mildly elevated IL-6 levels. The concentrations of IL-1 beta, IL-8, and IL-10 were normal in all patients. Upon treatment, ferritinemia ameliorated but S-ferritin levels did not normalize. The increased TNF-alpha level however, normalized in all treated patients, reaching the lowest values after 2 years of therapy and continued to be stable during the remaining 2 years of follow-up. Conclusions: Hyperferritinemia is a frequent finding in GD1 in Sweden. The relatively low hepcidin levels reveal a distorted relationship between hepcidin and ferritin in GD1. Therapy has the potential to not only ameliorate hyperferritinemia but to also normalize the serum TNF-alpha concentration in GD1.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
Nyckelord
- Gaucher disease
- Hyperferritinemia
- Cytokines
- TNF-alpha
- Enzyme replacement therapy
- Substrate reduction therapy
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas